Induced Pluripotent Stem Cells Market Size, Share & Trends Analysis Report By Derived Cell Type (Hepatocytes, Fibroblasts), By Application (Drug Development), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                        1.2.1. Derived Cell Type Segment
                        1.2.2. Application Segment
                        1.2.3. End Use Segment
                    1.3. Information analysis
                    1.4. Market formulation & data visualization
                    1.5. Data validation & publishing
                    1.6. Information Procurement
                        1.6.1. Primary Research
                    1.7. Information or Data Analysis
                    1.8. Market Formulation & Validation
                    1.9. Market Model
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Induced Pluripotent Stem Cells Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Rising prevalence of chronic diseases
                            3.2.1.2. Increasing research and development activities in stem cell therapies
                            3.2.1.3. Growing adoption of personalized medicine
                        3.2.2. Market restraint analysis
                            3.2.2.1. High cost of treatment
                    3.3. Induced Pluripotent Stem Cells Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                        3.3.2. PESTEL Analysis
                        3.3.3. COVID-19 Impact Analysis
Chapter 4. Induced Pluripotent Stem Cells Market: Derived Cell Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Global Induced Pluripotent Stem Cells Market Derived Cell Type Movement Analysis
                    4.3. Global Induced Pluripotent Stem Cells Market Size & Trend Analysis, by Derived Cell Type, 2018 to 2030 (USD Million)
                    4.4. Hepatocytes
                        4.4.1. Hepatocytes market estimates and forecasts 2018 - 2030 (USD Million)
                    4.5. Fibroblasts
                        4.5.1. Fibroblasts market estimates and forecasts 2018 - 2030 (USD Million)
                    4.6. Keratinocytes
                        4.6.1. Keratinocytes market estimates and forecasts 2018 - 2030 (USD Million)
                    4.7. Amniotic Cells
                        4.7.1. Amniotic cells market estimates and forecasts 2018 - 2030 (USD Million)
                    4.8. Others
                        4.8.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 5. Induced Pluripotent Stem Cells Market: Application Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Global Induced Pluripotent Stem Cells Market Application Movement Analysis
                    5.3. Global Induced Pluripotent Stem Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    5.4. Drug Development
                        5.4.1. Drug development market estimates and forecasts 2018 - 2030 (USD Million)
                    5.5. Tissue Engineering & Regenerative Medicine
                        5.5.1. Tissue engineering & regenerative medicine market estimates and forecasts 2018 - 2030 (USD Million)
                        5.5.2. Neurology
                            5.5.2.1. Neurology market estimates and forecasts 2018 - 2030 (USD Million)
                        5.5.3. Orthopedics
                            5.5.3.1. Orthopedics market estimates and forecasts 2018 - 2030 (USD Million)
                        5.5.4. Oncology
                            5.5.4.1. Oncology market estimates and forecasts 2018 - 2030 (USD Million)
                        5.5.5. Cardiovascular & Myocardial Infarction
                            5.5.5.1. Cardiovascular & myocardial infarction market estimates and forecasts 2018 - 2030 (USD Million)
                        5.5.6. Diabetes
                            5.5.6.1. Diabetes market estimates and forecasts 2018 - 2030 (USD Million)
                        5.5.7. Others
                            5.5.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
                    5.6. Toxicology Research
                        5.6.1. Toxicology research market estimates and forecasts 2018 - 2030 (USD Million)
                    5.7. Disease Modeling
                        5.7.1. Disease modeling market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 6. Induced Pluripotent Stem Cells Market: End Use Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Global Induced Pluripotent Stem Cells Market End Use Movement Analysis
                    6.3. Global Induced Pluripotent Stem Cells Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
                    6.4. Academic & Research Institutes
                        6.4.1. Academic & research institutes market estimates and forecasts 2018 - 2030 (USD Million)
                    6.5. Pharmaceutical & Biotechnology Companies
                        6.5.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 - 2030 (USD Million)
                    6.6. Others
                        6.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 7. Induced Pluripotent Stem Cells Market: Regional Estimates & Trend Analysis
                    7.1. Regional Market Share Analysis, 2023 & 2030
                    7.2. Regional Market Dashboard
                    7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    7.4. North America
                        7.4.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
                        7.4.2. U.S.
                            7.4.2.1. Key country dynamics
                            7.4.2.2. Competitive scenario
                            7.4.2.3. Regulatory framework
                            7.4.2.4. Target disease prevalence
                            7.4.2.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
                        7.4.3. Canada
                            7.4.3.1. Key country dynamics
                            7.4.3.2. Competitive scenario
                            7.4.3.3. Regulatory framework
                            7.4.3.4. Target disease prevalence
                            7.4.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
                        7.4.4. Mexico
                            7.4.4.1. Key country dynamics
                            7.4.4.2. Competitive scenario
                            7.4.4.3. Regulatory framework
                            7.4.4.4. Target disease prevalence
                            7.4.4.5. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
                    7.5. Europe
                        7.5.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
                        7.5.2. UK
                            7.5.2.1. Key country dynamics
                            7.5.2.2. Competitive scenario
                            7.5.2.3. Regulatory framework
                            7.5.2.4. Target disease prevalence
                            7.5.2.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
                        7.5.3. Germany
                            7.5.3.1. Key country dynamics
                            7.5.3.2. Competitive scenario
                            7.5.3.3. Regulatory framework
                            7.5.3.4. Target disease prevalence
                            7.5.3.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
                        7.5.4. France
                            7.5.4.1. Key country dynamics
                            7.5.4.2. Competitive scenario
                            7.5.4.3. Regulatory framework
                            7.5.4.4. Target disease prevalence
                            7.5.4.5. France market estimates and forecasts 2018 - 2030 (USD Million)
                        7.5.5. Italy
                            7.5.5.1. Key country dynamics
                            7.5.5.2. Competitive scenario
                            7.5.5.3. Regulatory framework
                            7.5.5.4. Target disease prevalence
                            7.5.5.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
                        7.5.6. Spain
                            7.5.6.1. Key country dynamics
                            7.5.6.2. Competitive scenario
                            7.5.6.3. Regulatory framework
                            7.5.6.4. Target disease prevalence
                            7.5.6.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
                        7.5.7. Denmark
                            7.5.7.1. Key country dynamics
                            7.5.7.2. Competitive scenario
                            7.5.7.3. Regulatory framework
                            7.5.7.4. Target disease prevalence
                            7.5.7.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
                        7.5.8. Sweden
                            7.5.8.1. Key country dynamics
                            7.5.8.2. Competitive scenario
                            7.5.8.3. Regulatory framework
                            7.5.8.4. Target disease prevalence
                            7.5.8.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
                        7.5.9. Norway
                            7.5.9.1. Key country dynamics
                            7.5.9.2. Competitive scenario
                            7.5.9.3. Regulatory framework
                            7.5.9.4. Target disease prevalence
                            7.5.9.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
                    7.6. Asia Pacific
                        7.6.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
                        7.6.2. Japan
                            7.6.2.1. Key country dynamics
                            7.6.2.2. Competitive scenario
                            7.6.2.3. Regulatory framework
                            7.6.2.4. Target disease prevalence
                            7.6.2.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
                        7.6.3. China
                            7.6.3.1. Key country dynamics
                            7.6.3.2. Competitive scenario
                            7.6.3.3. Regulatory framework
                            7.6.3.4. Target disease prevalence
                            7.6.3.5. China market estimates and forecasts 2018 - 2030 (USD Million)
                        7.6.4. India
                            7.6.4.1. Key country dynamics
                            7.6.4.2. Competitive scenario
                            7.6.4.3. Regulatory framework
                            7.6.4.4. Target disease prevalence
                            7.6.4.5. India market estimates and forecasts 2018 - 2030 (USD Million)
                        7.6.5. South Korea
                            7.6.5.1. Key country dynamics
                            7.6.5.2. Competitive scenario
                            7.6.5.3. Regulatory framework
                            7.6.5.4. Target disease prevalence
                            7.6.5.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
                        7.6.6. Australia
                            7.6.6.1. Key country dynamics
                            7.6.6.2. Competitive scenario
                            7.6.6.3. Regulatory framework
                            7.6.6.4. Target disease prevalence
                            7.6.6.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
                        7.6.7. Thailand
                            7.6.7.1. Key country dynamics
                            7.6.7.2. Competitive scenario
                            7.6.7.3. Regulatory framework
                            7.6.7.4. Target disease prevalence
                            7.6.7.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
                    7.7. Latin America
                        7.7.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
                        7.7.2. Brazil
                            7.7.2.1. Key country dynamics
                            7.7.2.2. Competitive scenario
                            7.7.2.3. Regulatory framework
                            7.7.2.4. Target disease prevalence
                            7.7.2.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
                        7.7.3. Argentina
                            7.7.3.1. Key country dynamics
                            7.7.3.2. Competitive scenario
                            7.7.3.3. Regulatory framework
                            7.7.3.4. Target disease prevalence
                            7.7.3.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
                    7.8. MEA
                        7.8.1. MEA market estimates and forecasts 2018 - 2030 (USD Million)
                        7.8.2. South Africa
                            7.8.2.1. Key country dynamics
                            7.8.2.2. Competitive scenario
                            7.8.2.3. Regulatory framework
                            7.8.2.4. Target disease prevalence
                            7.8.2.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
                        7.8.3. Saudi Arabia
                            7.8.3.1. Key country dynamics
                            7.8.3.2. Competitive scenario
                            7.8.3.3. Regulatory framework
                            7.8.3.4. Target disease prevalence
                            7.8.3.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
                        7.8.4. UAE
                            7.8.4.1. Key country dynamics
                            7.8.4.2. Competitive scenario
                            7.8.4.3. Regulatory framework
                            7.8.4.4. Target disease prevalence
                            7.8.4.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
                        7.8.5. Kuwait
                            7.8.5.1. Key country dynamics
                            7.8.5.2. Competitive scenario
                            7.8.5.3. Regulatory framework
                            7.8.5.4. Target disease prevalence
                            7.8.5.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Company/Competition Categorization
                    8.2. Strategy Mapping
                    8.3. Company Market Position Analysis, 2023
                    8.4. Company Profiles/Listing
                        8.4.1. STEMCELL Technologies Inc.
                            8.4.1.1. Company overview
                            8.4.1.2. Financial performance
                            8.4.1.3. Product benchmarking
                            8.4.1.4. Strategic initiatives
                        8.4.2. Cellular Engineering Technologies Inc.
                            8.4.2.1. Company overview
                            8.4.2.2. Financial performance
                            8.4.2.3. Product benchmarking
                            8.4.2.4. Strategic initiatives
                        8.4.3. REPROCELL Inc.
                            8.4.3.1. Company overview
                            8.4.3.2. Financial performance
                            8.4.3.3. Product benchmarking
                            8.4.3.4. Strategic initiatives
                        8.4.4. Takara Bio, Inc.
                            8.4.4.1. Company overview
                            8.4.4.2. Financial performance
                            8.4.4.3. Product benchmarking
                            8.4.4.4. Strategic initiatives
                        8.4.5. Axol Bioscience Ltd.
                            8.4.5.1. Company overview
                            8.4.5.2. Financial performance
                            8.4.5.3. Product benchmarking
                            8.4.5.4. Strategic initiatives
                        8.4.6. Fate Therapeutics, Inc.
                            8.4.6.1. Company overview
                            8.4.6.2. Financial performance
                            8.4.6.3. Product benchmarking
                            8.4.6.4. Strategic initiatives
                        8.4.7. FUJIFILM Cellular Dynamics, Inc.
                            8.4.7.1. Company overview
                            8.4.7.2. Financial performance
                            8.4.7.3. Product benchmarking
                            8.4.7.4. Strategic initiatives
                        8.4.8. Cynata Therapeutics Limited
                            8.4.8.1. Company overview
                            8.4.8.2. Financial performance
                            8.4.8.3. Product benchmarking
                            8.4.8.4. Strategic initiatives
                        8.4.9. Evotec SE
                            8.4.9.1. Company overview
                            8.4.9.2. Financial performance
                            8.4.9.3. Product benchmarking
                            8.4.9.4. Strategic initiatives
                        8.4.10. Astellas Pharma Inc.
                            8.4.10.1. Company overview
                            8.4.10.2. Financial performance
                            8.4.10.3. Product benchmarking
                            8.4.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 Global induced pluripotent stem cells market, by region, 2018 - 2030 (USD Million)
Table 3 Global induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 4 Global induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 5 Global induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 6 North America induced pluripotent stem cells market, by country, 2018 - 2030 (USD Million)
Table 7 North America induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 8 North America induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 9 North America induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 11 U.S. induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 14 Canada induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 15 Canada induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 17 Mexico induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe induced pluripotent stem cells market, by country, 2018 - 2030 (USD Million)
Table 20 Europe induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 21 Europe induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 22 Europe induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 24 Germany induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 25 Germany induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 26 UK induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 27 UK induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 28 UK induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 29 France induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 30 France induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 31 France induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 33 Italy induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 34 Italy induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 36 Spain induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 37 Spain induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 39 Denmark induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 42 Sweden induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 44 Norway induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 45 Norway induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 46 Norway induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific induced pluripotent stem cells market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 51 China induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 52 China induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 53 China induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 54 Japan induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 55 Japan induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 56 Japan induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 57 India induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 58 India induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 59 India induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 60 South Korea induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 61 South Korea induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 62 South Korea induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 63 Australia induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 64 Australia induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 65 Australia induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 67 Thailand induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America induced pluripotent stem cells market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 71 Latin America induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 72 Latin America induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 73 Brazil induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 74 Brazil induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 77 Argentina induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 79 MEA induced pluripotent stem cells market, by country, 2018 - 2030 (USD Million)
Table 80 MEA induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 81 MEA induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 82 MEA induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 83 South Africa induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 84 South Africa induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 89 UAE induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 90 UAE induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 91 UAE induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)
Table 92 Kuwait induced pluripotent stem cells market, by derived cell type, 2018 - 2030 (USD Million)
Table 93 Kuwait induced pluripotent stem cells market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait induced pluripotent stem cells market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Induced pluripotent stem cells market: Market outlook
Fig. 5 Induced pluripotent stem cells market: Segment outlook
Fig. 6 Induced pluripotent stem cells market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Induced pluripotent stem cells market driver impact
Fig. 9 Induced pluripotent stem cells market restraint impact
Fig. 10 Induced pluripotent stem cells market: Type outlook and key takeaways
Fig. 11 Induced pluripotent stem cells market: Type movement analysis
Fig. 12 Hepatocytes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Fibroblasts market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Keratinocytes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Amniotic cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Induced pluripotent stem cells market: Application outlook and key takeaways
Fig. 18 Induced pluripotent stem cells market: Application movement analysis
Fig. 19 Drug development market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Tissue engineering & regenerative medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Neurology market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 22 Orthopedics market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 23 Oncology market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 24 Cardiovascular and myocardial infarction market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 25 Diabetes market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 26 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 27 Toxicology research market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 28 Disease modeling market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 29 Induced pluripotent stem cells market: End use outlook and key takeaways
Fig. 30 Induced pluripotent stem cells market: End use movement analysis
Fig. 31 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Global induced pluripotent stem cells market: Regional outlook and key takeaways
Fig. 35 Global induced pluripotent stem cells market: Regional movement analysis
Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Key country dynamics
Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)